Human Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 1 (NFKB1) Protein (Myc-DYKDDDDK Tag), Recombinant | ABIN2727210
![Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS](https://www.pnas.org/cms/10.1073/pnas.1901734117/asset/3df9a166-9499-4800-a9f7-49e5fac85081/assets/graphic/pnas.1901734117fig01.jpeg)
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
![Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy | European Journal of Medical Research | Full Text Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy | European Journal of Medical Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F2047-783X-14-2-47/MediaObjects/40001_2008_Article_189_Fig3_HTML.jpg)
Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy | European Journal of Medical Research | Full Text
![Serum protein electrophoresis in both patients. Case 1 shows a 34 g/L... | Download Scientific Diagram Serum protein electrophoresis in both patients. Case 1 shows a 34 g/L... | Download Scientific Diagram](https://www.researchgate.net/publication/344151355/figure/fig1/AS:952588862242817@1604126291215/Serum-protein-electrophoresis-in-both-patients-Case-1-shows-a-34-g-L-IgG-kappa_Q640.jpg)
Serum protein electrophoresis in both patients. Case 1 shows a 34 g/L... | Download Scientific Diagram
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
![SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci](https://www.prosci-inc.com/wp-content/uploads/2021/12/SARS-CoV-2-COVID-19-full-length-Spike-S1-Kappa-India-Dec-2020-B-1-617-1-Variant-Recombinant-Protein_SDS_21-823.jpg)
SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
![SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci](https://www.prosci-inc.com/wp-content/uploads/2021/12/SARS-CoV-2-COVID-19-full-length-Spike-S1-Kappa-India-Dec-2020-B-1-617-1-Variant-Recombinant-Protein_picture_21-823.jpg)
SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci
![Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation](http://www.scielo.org.za/img/revistas/samj/v109n10/08f01.jpg)